RGCC International

23/04/2026

Why do healthcare practitioners choose testing?

For Dr. Clayton Bell, it's the personalized treatment approaches that are offered through our testing.

👓 Read more testimonials from healthcare practitioners and patients here: rgcc-international.com/testimonials/

20/04/2026

Liquid biopsy cancer testing allows for the detection and analysis of key cancer-related components circulating in the bloodstream, including circulating tumor cells (CTCs) and markers. These insights support cancer detection, diagnosis, and continuous monitoring of disease progression over time.

👉 RGCC cancer tests are designed to deliver clinically relevant results across the full care journey. Learn more: rgcc-international.com/tests/

16/04/2026

Throwback post for our in-depth review published in February 2024 by scientists on survival analysis methods in clinical studies. This article explores both introductory and advanced techniques in survival modeling, highlighting the importance of accurate statistical methods when analyzing time-to-event data in clinical trials.

With a focus on improving the accuracy of survival analysis, this article aims to enhance understanding and interpretation of medical studies, helping clinicians make better-informed treatment decisions.

🔗 Read the full article here:

The time-to-event relationship for survival modeling is considered when designing a study in clinical trials. However, because time-to-event data are mostly not normally distributed, survival analysis uses non-parametric data processing and analysis methods, mainly Kaplan–Meier (KM) estimation mod...

13/04/2026

Onco-D-Clare is an advanced cancer screening blood test designed to detect early biological changes linked to cancer, based on each individual’s genetic profile, even before symptoms appear.

Watch the video below to hear how healthcare practitioners are using the test in clinical practice and the impact it’s having on patient care.

08/04/2026

We’re excited to be featured in Finanz und Wirtschaft’s special issue, “Invest in Health.”

In this interview, our Founder and CEO, Dr. Ioannis Papasotiriou, shares insights on the growing importance of prevention and innovation in healthcare.

📖 Scroll to page 5 to read the full interview (in German):

Welcome to Issuu's blog: home to product news, tips, resources, interviews (and more) related to content marketing and publishing.

01/04/2026

At , we support healthcare professionals in delivering precision at every stage of the patient journey, from early detection to treatment guidance and long-term monitoring.

Empower your clinical decisions with RGCC’s comprehensive portfolio of advanced diagnostic tests.

🧬 Explore our tests: rgcc-international.com/tests

25/03/2026

Early detection can make a critical difference in cancer care.

In this short video, Dr. Ana Paz, a medical practitioner in Lisbon, Portugal, shares her experience using RGCC testing in clinical practice. Working within a multidisciplinary clinic, she explains how circulating tumor cell (CTC) analysis can support cancer screening and patient monitoring.

Dr. Paz also shares a personal story from within her own family, where RGCC testing detected circulating tumor cells before conventional imaging identified a developing tumor. This early insight enabled timely intervention and treatment.

Experiences like this highlight the potential of advanced diagnostic tools to support earlier detection and more informed clinical decision-making.

▶️ Watch the full interview on YouTube: https://www.youtube.com/watch?v=sfTVxKtdoC0

19/03/2026

What is the optimal strategy for adjusting second-line treatment for advanced pancreatic using circulating cells (CTCs)?

Developed through a collaboration between scientists and clinical oncologists, our 2025 study: "Second-line therapy adjustment for advanced pancreatic cancer using circulating tumor cells: Preliminary results," investigates the potential of to guide second-line chemotherapy decisions in advanced pancreatic , offering a personalized approach.

👉 Click here to read all our published studies:

Experts in developing and providing personalised cancer genetic tests for doctors and patients, RGCC is a specialist medical genetics company based in Switzerland, with laboratories worldwide.

16/03/2026

Metastat is an advanced diagnostic test that investigates the proteins and genes associated with the metastatic spread of . By analyzing circulating tumor cells (CTCs) from the patient’s blood sample, the test can help determine whether the cells have a high likelihood of metastasizing or if a secondary cancerous tumor is likely to develop, and where in the body it may occur.

🔗 Learn more: rgcc-international.com/tests/metastat/

12/03/2026

Last month, as part of his official tour of Northern Greece, the Ambassador of Indonesia, H.E. Dr. Bebeb A.K. Nugraha Djundjunan, visited RGCC’s laboratories in Florina.

During his visit, the Ambassador was given a guided tour of RGCC’s state-of-the-art facilities and was introduced to the company’s research activities and innovations in precision .

The visit concluded with a shared expression of intent to strengthen collaboration through the exchange of expertise and resources.

Would you like to stay up to date with our latest news, research, and events?
🔗 Subscribe to our newsletter: rgcc-international.com/join-our-mailing-list/

08/03/2026

On International Women’s Day 2026, we celebrate the women whose expertise, leadership, and dedication drive progress in worldwide.

At Central Europe in Halle (Saale), women represent more than 80% of our team: scientists, team members, and leaders shaping the future of oncology and precision medicine.

Today, we honor the journeys, ambition, and impact of the women advancing research and improving patient care worldwide.

05/03/2026

Every patient journey is unique, and so is the care they deserve.

P.W.’s testimonial reflects our commitment to combining advanced diagnostics with compassionate, patient-centered care, supporting informed treatment decisions at every step.

🌱 Read more patient stories: rgcc-international.com/testimonials/